Literature DB >> 34261944

Transfusion Practices in Pediatric Cardiac Surgery Requiring Cardiopulmonary Bypass: A Secondary Analysis of a Clinical Database.

Sheila J Hanson1, Oliver Karam2, Rebecca Birch3, Ruchika Goel4, Ravi M Patel5, Martha Sola-Visner6, Bruce S Sachais7, Ronald G Hauser8, Naomi L C Luban9, Jerome Gottschall1, Cassandra D Josephson5, Jeanne E Hendrickson8, Matthew S Karafin10, Marianne E Nellis11.   

Abstract

OBJECTIVES: To describe blood component usage in transfused children with congenital heart disease undergoing cardiopulmonary bypass surgery across perioperative settings and diagnostic categories.
DESIGN: Datasets from U.S. hospitals participating in the National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study-III were analyzed.
SETTING: Inpatient admissions from three U.S. hospitals from 2013 to 2016. PATIENTS: Transfused children with congenital heart disease undergoing single ventricular, biventricular surgery, extracorporeal membrane oxygenation.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Eight hundred eighty-two transfused patients were included. Most of the 185 children with single ventricular surgery received multiple blood products: 81% RBCs, 79% platelets, 86% plasma, and 56% cryoprecipitate. In the 678 patients undergoing biventricular surgery, 85% were transfused plasma, 75% platelets, 74% RBCs, and 48% cryoprecipitate. All 19 patients on extracorporeal membrane oxygenation were transfused RBCs, plasma, and cryoprecipitate, and 18 were transfused platelets. Intraoperatively, patients commonly received all three components, while postoperative transfusions were predominantly single blood components. Pretransfusion hemoglobin values were normal/low-normal for age for all phases of care for single ventricular surgery (median hemoglobin 13.2-13.5 g/dL). Pretransfusion hemoglobin values for biventricular surgeries were higher intraoperatively compared with other timing (12.2 g/dL vs 11.2 preoperative and postoperative; p < 0.0001). Plasma transfusions for all patients were associated with a near normal international normalized ratio: single ventricular surgeries median international normalized ratio was 1.3 postoperative versus 1.8 intraoperative and biventricular surgeries median international normalized ratio was 1.1 intraoperative versus 1.7 postoperative. Intraoperative platelet transfusions with biventricular surgeries had higher median platelet count compared with postoperative pretransfusion platelet count (244 × 109/L intraoperative vs 69 × 109/L postoperative).
CONCLUSIONS: Children with congenital heart disease undergoing cardiopulmonary bypass surgery are transfused many blood components both intraoperatively and postoperatively. Multiple blood components are transfused intraoperatively at seemingly normal/low-normal pretransfusion values. Pediatric evidence guiding blood component transfusion in this population at high risk of bleeding and with limited physiologic reserve is needed to advance safe and effective blood conservation practices.
Copyright © 2021 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Entities:  

Mesh:

Year:  2021        PMID: 34261944      PMCID: PMC8570986          DOI: 10.1097/PCC.0000000000002805

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  26 in total

Review 1.  Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials.

Authors:  Lucy Yang; Simon Stanworth; Sally Hopewell; Carolyn Doree; Mike Murphy
Journal:  Transfusion       Date:  2012-01-18       Impact factor: 3.157

2.  Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial.

Authors:  D H de Gast-Bakker; R B P de Wilde; M G Hazekamp; V Sojak; J J Zwaginga; R Wolterbeek; E de Jonge; B J Gesink-van der Veer
Journal:  Intensive Care Med       Date:  2013-08-31       Impact factor: 17.440

3.  Multiple Electrode Aggregometry After Cardiopulmonary Bypass to Assess Platelet (Dys)-Function and Transfusion Threshold: A Concordance Study.

Authors:  Elisabetta Auci; Luigi Vetrugno; Ilaria Riccardi; Alessandro Brussa; Daniele Orso; Antonio Baroselli; Andrea Gigante; Roberta Cecotti; Flavio Bassi; Ugolino Livi; Tiziana Bove
Journal:  J Cardiothorac Vasc Anesth       Date:  2020-06-24       Impact factor: 2.628

4.  Development of a specific algorithm to guide haemostatic therapy in children undergoing cardiac surgery: a single-centre retrospective study.

Authors:  David Faraoni; Ariane Willems; Birgitta S Romlin; Sylvain Belisle; Philippe Van der Linden
Journal:  Eur J Anaesthesiol       Date:  2015-05       Impact factor: 4.330

5.  Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial.

Authors:  Ludhmila A Hajjar; Jean-Louis Vincent; Filomena R B G Galas; Rosana E Nakamura; Carolina M P Silva; Marilia H Santos; Julia Fukushima; Roberto Kalil Filho; Denise B Sierra; Neuza H Lopes; Thais Mauad; Aretusa C Roquim; Marcia R Sundin; Wanderson C Leão; Juliano P Almeida; Pablo M Pomerantzeff; Luis O Dallan; Fabio B Jatene; Noedir A G Stolf; Jose O C Auler
Journal:  JAMA       Date:  2010-10-13       Impact factor: 56.272

6.  Platelet Transfusion Practices in Critically Ill Children.

Authors:  Marianne E Nellis; Oliver Karam; Elizabeth Mauer; Melissa M Cushing; Peter J Davis; Marie E Steiner; Marisa Tucci; Simon J Stanworth; Philip C Spinella
Journal:  Crit Care Med       Date:  2018-08       Impact factor: 7.598

7.  Individualized, Intraoperative Dosing of Fibrinogen Concentrate for the Prevention of Bleeding in Neonatal and Infant Cardiac Surgery Using Cardiopulmonary Bypass (FIBCON): A Phase 1b/2a Randomized Controlled Trial.

Authors:  Kristina Siemens; Beverley J Hunt; Julia Harris; Andrew G Nyman; Kiran Parmar; Shane M Tibby
Journal:  Circ Cardiovasc Interv       Date:  2020-11-20       Impact factor: 6.546

8.  Risks and predictors of blood transfusion in pediatric patients undergoing open heart operations.

Authors:  Andrea Székely; Zsuzsanna Cserép; Erzsébet Sápi; Tamás Breuer; Csaba A Nagy; Péter Vargha; István Hartyánszky; András Szatmári; András Treszl
Journal:  Ann Thorac Surg       Date:  2009-01       Impact factor: 4.330

9.  Children with single-ventricle physiology do not benefit from higher hemoglobin levels post cavopulmonary connection: results of a prospective, randomized, controlled trial of a restrictive versus liberal red-cell transfusion strategy.

Authors:  Jill M Cholette; Jeffrey S Rubenstein; George M Alfieris; Karen S Powers; Michael Eaton; Norma B Lerner
Journal:  Pediatr Crit Care Med       Date:  2011-01       Impact factor: 3.624

10.  Platelet transfusion: a clinical practice guideline from the AABB.

Authors:  Richard M Kaufman; Benjamin Djulbegovic; Terry Gernsheimer; Steven Kleinman; Alan T Tinmouth; Kelley E Capocelli; Mark D Cipolle; Claudia S Cohn; Mark K Fung; Brenda J Grossman; Paul D Mintz; Barbara A O'Malley; Deborah A Sesok-Pizzini; Aryeh Shander; Gary E Stack; Kathryn E Webert; Robert Weinstein; Babu G Welch; Glenn J Whitman; Edward C Wong; Aaron A R Tobian
Journal:  Ann Intern Med       Date:  2015-02-03       Impact factor: 25.391

View more
  1 in total

1.  The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): A research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan.

Authors:  Cassandra D Josephson; Simone Glynn; Sunitha Mathew; Rebecca Birch; Sonia Bakkour; Lisa Baumann Kreuziger; Michael P Busch; Kathleen Chapman; Carla Dinardo; Jeanne Hendrickson; Eldad A Hod; Shannon Kelly; Naomi Luban; Alan Mast; Philip Norris; Brian Custer; Ester Sabino; Bruce Sachais; Bryan R Spencer; Mars Stone; Steve Kleinman
Journal:  Transfusion       Date:  2022-04-19       Impact factor: 3.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.